Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
A.G. Zaman, G. Helft, S.G. Worthley, J.J. Badimon.
The role of plaque rupture and thrombosis in coronary artery disease.
Atherosclerosis, 149 (2000), pp. 251-266
[2.]
V. Fuster, L. Badimon, J.J. Badimon, J.H. Chesebro.
The pathogenesis of coronary artery disease and the acute coronary syndromes (1.
N Engl J Med, 326 (1992), pp. 242-250
[3.]
H. Wellens.
Cardiology: where to go from here?.
Lancet, 354 (1999), pp. 8-10
[4.]
C. Von Rokitansky.
A manual of pathological anatomy, Berlin, Syndheman Soc, 4 (1852), pp. 261
[5.]
N. Anitschow, S. Chalatow.
Uber experimentelle Cholesterinstectase und ihre Bedeutung fur die Entstehung einiger pathologischer Prozesse.
Centralbl Allg Path Anot, (1913), pp. 1-24
[6.]
M.A. Gimbrone.
Endothelial dysfunction, hemodynamic forces, and atherosclerosis.
Thromb Haemost, 82 (1999), pp. 722-726
[7.]
D.N. Ku, D.P. Giddens, C.K. Zarins, S. Glagov.
Pulsatile flow and atherosclerosis in the human carotid bifurcation: positive correlation between plaque location and low oscillating shear stress.
Arteriosclerosis, 5 (1985), pp. 293-302
[8.]
A.M. Malek, S.L. Alper, S. Izunmo.
Hemodynamic shear stress and its role in atherosclerosis.
JAMA, 282 (1999), pp. 2035-4220
[9.]
J.N. Topper, J. Cai, D. Falb, M.A.J. Gimbrone.
Identification of vascular endothelial genes differentially responsive to fluid mechanical stimuli: cyclooxygenase-2, manganese superoxide dismutase, and endothelial cell nitric oxide synthase are selectively up-regulated by steady laminar shear stress.
Proc Natl Acad Sci USA, 93 (1996), pp. 10417-10422
[11.]
P.M. Vanhoutte.
Endothelium dysfunction and atherosclerosis.
Eur Heart J, 18 (1997), pp. 19-29
[12.]
G. Camejo, E. Hurt-Camejo, O. Wiklund, G. Bondjers.
Association of apo B lipoproteins with arterial proteoglycans: pathological significance and molecular basis.
Atherosclerosis, 139 (1998), pp. 205-222
[13.]
J.A. Berliner, M. Navab, A.M. Fogelman, J.S. Frank, L.L. Demer, P.A. Edwards, et al.
Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics.
Circulation, 91 (1995), pp. 2486-2496
[14.]
G.K. Hansson.
Immune mechanisms in atherosclerosis.
Arterioscler Thromb Vasc Biol, 21 (2001), pp. 1876-1890
[15.]
R. Ross.
Atherosclerosis-an inflammatory disease.
N Engl J Med, 340 (1999), pp. 115-126
[16.]
T. Collins, M.A. Read, A.S. Neish, M.Z. Whitley, D. Thanos, T. Maniatis.
Transcriptional regulation of endothelial cell adhesion molecules: NF-kappa B and cytokine-inducible enhancers.
FASEB J, 9 (1995), pp. 899-909
[17.]
R. De Caterina, T. Bourcier, U. Laufs, V. LaFata, G. Lazzerini, A.S. Neish, et al.
Induction of endothelial-leukocyte interaction by interferon-gamma requires coactivation of nuclear factor-kappaB.
Arterioscler Thromb Vasc Biol, 21 (2001), pp. 227-232
[18.]
R.G. Collins, R. Velji, N.V. Guevara, M.J. Hicks, L. Chan, A.L. Beaudet.
P-Selectin or intercellular adhesión molecule (ICAM) -1 deficiency substantially protects against atherosclerosis in apolipoprotein E-deficient mice.
J Exp Med, 191 (2000), pp. 189-194
[19.]
Z.M. Dong, S.M. Chapman, A.A. Brown, P.S. Frenette, R.O. Hynes, D.D. Wagner.
The combined role of P- and E-selectins in atherosclerosis.
J Clin Invest, 102 (1998), pp. 145-152
[20.]
L. Gu, Y. Okada, S.K. Clinton, C. Gerard, G.K. Sukhova, P. Libby, et al.
Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice.
Mol Cell, 2 (1998), pp. 275-281
[21.]
S.J. Hwang, C.M. Ballantyne, A.R. Sharrett, L.C. Smith, C.E. Davis, A.M.J. Gotto, et al.
Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) study.
Circulation, 96 (1997), pp. 4219-4225
[22.]
L.E. Rohde, C.H. Hennekens, P.M. Ridker.
Survey of C-reactive protein and cardiovascular risk factors in apparently healthy men.
Am J Cardiol, 84 (1999), pp. 1018-1022
[23.]
S.E. Nissen, P. Yock.
Intravascular ultrasound: novel pathophysiological insights and current clinical applications.
Circulation, 103 (2001), pp. 604-616
[24.]
P. Schoenhagen, K.M. Ziada, S.R. Kapadia, T.D. Crowe, S.E. Nissen, E.M. Tuzcu.
Extent and direction of arterial remodeling in stable versus unstable coronary syndromes: an intravascular ultrasound study.
Circulation, 101 (2000), pp. 598-603
[25.]
R. tCorti, Z.A. Fayad, V. Fuster, S.G. Worthley, G. Helft, J.H. Chesebro, et al.
Effects of lipid-lowering by simvastatin on human atherosclerotic lesions: a longitudinal study by high-resolution, non-invasive MRI.
Circulation, 104 (2001), pp. 249-252
[26.]
R. Corti, V. Fuster, J.J. Badimon, R. Hutter, Z.A. Fayad.
New understanding of atherosclerosis (clinically and experimentally) with evolving in vivo MRI technology.
Ann NY Acad Sci, 947 (2001), pp. 181-195
[27.]
D.J. Lefer, D.N. Granger.
Oxidative stress and cardiac disease.
Am J Med, 109 (2000), pp. 315-323
[28.]
K.K. Griendling, R.W. Alexander.
Oxidative stress and cardiovascular disease.
Circulation, 96 (1997), pp. 3264-3265
[29.]
M. Navab, J.A. Berliner, A.D. Watson, S.Y. Hama, M.C. Territo, A.J. Lusis, et al.
The Yin and Yang of oxidation in the development of the fatty streak: a review based on the 1994 George Lyman Duff Memorial Lecture.
Arterioscler Thromb Vasc Biol, 16 (1996), pp. 831-842
[30.]
H.C. Stary.
Evolution and progressión of atherosclerotic lesiones in coronary arteries of children and young adults.
Arteriosclerosis Thromb Vasc Biol, 9 (Suppl 1 (1989), pp. 19-132
[31.]
R. Virmani, F.D. Kolodgie, A.P. Burke, A. Farb, S.M. Schwartz.
Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions.
Arterioscler Thromb Vasc Biol, 20 (2000), pp. 1262-1275
[32.]
J.L. Goldstein, R.G. Anderson, M.S. Brown.
Coated pits, coated vesicles, and receptor-mediated endocytosis.
Nature, 279 (1979), pp. 679-685
[33.]
M. Febbraio, E.A. Podrez, J.D. Smith, D.P. Hajjar, S.L. Hazen, H.F. Hoff, et al.
Tar-geted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice.
J Clin Invest, 105 (2000), pp. 1049-1056
[34.]
M.R. Bennett.
Apoptosis of vascular smooth muscle cells in vascular remodelling and atherosclerotic plaque rupture.
Cardiovasc Res, 41 (1999), pp. 361-368
[35.]
J.A. Glomset.
The plasma lecithin:cholesterol acyltransferase reaction.
J Lipid Res, 9 (1968), pp. 155-167
[36.]
J.J. Badimon, L. Badimon, V. Fuster.
Regressión of atherosclerotic lesions by high density lipoprotein plasma fractions in the cholesterol-fed rabbit.
J Clin Invest, 85 (1990), pp. 1234-1241
[37.]
J.J. Badimon, L. Badimon, A. Gálvez, R. Dische, V. Fuster.
The high density lipoprotein plasma fractions inhibit aortic fatty streak in cholesterol-fed rabbits.
Lab Invest, 60 (1989), pp. 455-461
[38.]
N. Duverger, H. Kruth, F. Emmanuel, J.M. Caillaud, C. Viglietta, G. Castro, et al.
Inhibition of atherosclerosis development in cholesterol-fed human apolipoprotein A-I-transgenic rabbits.
Circulation, 94 (1996), pp. 713-717
[39.]
A.S. Plump, C.J. Scott, J.L. Breslow.
Human apolipoprotein A-I gene expression increases high density lipoprotein and suppresses atherosclerosis in the apolipoprotein E-deficient mouse.
Proc Natl Acad Sci U S A, 91 (1994), pp. 9607-9611
[40.]
P.K. Shah, J. Yano, O. Reyes, K.Y. Chyu, S. Kaul, C.L. Bisgaier, et al.
High-dose recombinant apolipoprotein A-I (milano) mobilizes tissue cholesterol and rapidly reduces plaque lipid and macrophage content in apolipoprotein e-deficient mice. Potential implications for acute plaque stabilization.
Circulation, 103 (2001), pp. 3047-3050
[41.]
M. Navab, G.M. Anantharamaiah, S. Hama, D.W. Garber, M. Chaddha, G. Hough, et al.
Oral administration of an Apo A-I mimetic Peptide synthesized from Damino acids dramatically reduces atherosclerosis in mice independent of plasma cholesterol.
Circulation, 105 (2002), pp. 290-292
[42.]
T. Gordon, J.L. Probstfield, R.J. Garrison, J.D. Neaton, W.P. Castelli, J.D. Knoke.
HDL and cardiovascular diseases: Four prospective studies.
Circulation, 79 (1989), pp. 8-15
[43.]
A.M.J. Gotto, E. Whitney, E.A. Stein, D.R. Shapiro, M. Clearfield, S. Weiss, et al.
Relation between baseline and on-treatment lipid parameters and first acute major coronary events in the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS.
Circulation, (2000), pp. 477-484
[44.]
G. Assman, H. Schulte, A. Von Eckardstein, Y. Huang.
HDL-cho as a predictor of CHD: the PROCAM experience and pathophysiological implications for reverse cholesterol transport.
Atherosclerosis, 124 (1996), pp. 11-20
[45.]
V. Manninen, M.O. Elo, M.H. Frick, K. Haapa, O.P. Heinonen, P. Heinsalmi.
Lipid alterations and decline in the incidence of coronary heart disease in the Helsinki Heart Study.
JAMA, 260 (1988), pp. 641-651
[46.]
H.B. Rubins, S.J. Robins, D. Collins, C.L. Fye, J.W. Anderson, M.B. Elam.
Gemfibrozil for the secondary prevention on coronary heart disease in men with low levels of high density lipoprotein cholesterol.
N Engl J Med, 341 (1999), pp. 410-418
[47.]
Expert Panel on Detection E, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III).
J Am Med Assoc, 285 (2001), pp. 2486-2497
[48.]
J.C. Choy, D.J. Granville, D.W. Hunt, B.M. McManus.
Endothelial cell apoptosis: biochemical characteristics and potential implications for atherosclerosis.
J Mol Cell Cardiol, 33 (2001), pp. 1673-1690
[49.]
S.W. Fesik, Y. Shi.
Controlling the caspases.
Science, 294 (2001), pp. 1477-1478
[50.]
Y.J. Geng, L.E. Henderson, E.B. Levesque, M. Muszynski, P. Libby.
Fas is expressed in human atherosclerotic intima and promotes apoptosis of cytokine-primed human vascular smooth muscle cells.
Arterioscler Thromb Vasc Biol, 17 (1997), pp. 2200-2208
[51.]
F.D. Kolodgie, J. Narula, N. Haider, R. Virmani.
Apoptosis in atherosclerosis. Does it contribute to plaque instability?.
Cardiol Clin, 19 (2001), pp. 127-139
[52.]
R.A. Gottlieb, R.N. Kitsis.
Seeing death in the living.
Nature Med, 7 (2001), pp. 1277-1278
[53.]
X. Roucou, B. Antonsson, J.C. Martinou.
Involvement of mitochondria in apoptosis.
Cardiol Clin, 19 (2001), pp. 45-55
[54.]
M.J. Davies.
Going from immutable to mutable atherosclerotic plaques.
Am J Cardiol, 88 (2001), pp. 2-9
[55.]
E. Falk, P.K. Shah, V. Fuster.
Coronary plaque disruption.
Circulation, 92 (1995), pp. 657-671
[56.]
J.A. Ambrose, M.A. Tannenbaum, D. Alexopoulos, C.E. Hjemdahl-Monson, J. Leavy, M. Weiss, et al.
Angiographic progressión of coronary artery disease and the development of myocardial infarction.
J Am Coll Cardiol, 12 (1988), pp. 56-62
[57.]
D. Giroud, J.M. Li, P. Urban, B. Meier, W. Rutishauser.
Relation of the site of acute myocardial infarction to the most severe coronary arterial stenosis at prior angiography.
Am J Cardiol, 69 (1992), pp. 729-732
[58.]
W.C. Little, M. Constantinescu, R.J. Applegate, M.A. Kutcher, M.T. Burrows, F.R. Kahl, et al.
Can coronary angiography predict the site of a subsequent myocardial infarction in patients with mild to moderate coronary artery disease?.
Circulation, 78 (1988), pp. 1157-1166
[59.]
F.D. Kolodgie, A.P. Burke, A. Farb, H.K. Gold, J. Yuan, J. Narula, et al.
The thincap fibroatheroma: a type of vulnerable plaque: the major precursor lesión to acute coronarysyndromes.
Curr Opin Cardiol, 16 (2001), pp. 285-292
[60.]
P.R. Moreno, V.H. Bernardi, J. López-Cuéllar, A.M. Murcia, I.F. Palacios, H.K. Gold, et al.
Macrophages, smooth muscle cells, and tissue factor in unstable angina. Implications for cell-mediated thrombogenicity in acute coronary syndromes.
Circulation, 94 (1996), pp. 3090-3097
[61.]
P.R. Moreno, E. Falk, I.F. Palacios, J.B. Newell, V. Fuster, J.T. Fallon.
Macrophage infiltration in acute coronary syndromes: implications for plaque rupture.
Circulation, 90 (1994), pp. 775-778
[62.]
A. Farb, A.P. Burke, A.L. Tang, Y. Liang, P. Mannan, J. Smialek, et al.
Coronary plaque erosion without rupture into a lipid core: a frequent cause of coronary thrombosis in sudden coronary death.
Circulation, 93 (1996), pp. 1354-1363
[63.]
P.K. Shah, E. Falk, J.J. Badimon, A. Fernández-Ortiz, A. Mailhac, G. Villareal-Levy, et al.
Human monocyte-derived macrophages induce collagen breakdown in fibrous caps of atherosclerotic plaques. Potential role of matrix-degrading metalloproteinases and implications for plaque rupture.
Circulation, 92 (1995), pp. 1565-1569
[64.]
G.K. Sukhova, U. Schonbeck, E. Rabkin, F.J. Schoen, A.R. Poole, R.C. Billinghurst, et al.
Evidence for increased collagenolysis by interstitial collagenases-1 and -3 in vulnerable human atheromatous plaques.
Circulation, 99 (1999), pp. 2503-2509
[65.]
G.K. Sukhova, G.P. Shi, D.I. Simon, H.A. Chapman, P. Libby.
Expression of the elastolytic cathepsins S and K in human atheroma and regulation of their production in smooth muscle cells.
J Clin Invest, 102 (1998), pp. 576-583
[66.]
U. Schonbeck, G.K. Sukhova, K. Shimizu, F. Mach, P. Libby.
Inhibition of CD40 signaling limits evolution of established atherosclerosis in mice.
Proc Natl Acad Sci USA, 97 (2000), pp. 458-463
[68.]
P.K. Shah, Z.S. Galis.
Matrix metalloproteinase hypothesis of plaque rupture: players keep piling up but questions remain.
Circulation, 104 (2001), pp. 1878-1880
[69.]
G.T. Gerhard, P.B. Duell.
Homocysteine and atherosclerosis.
Curr Opin Lipidol, 10 (1999), pp. 417-428
[70.]
N. Negoro, Y. Kanayama, M. Haraguchi, N. Umetani, M. Nishimura, Y. Konishi, et al.
Blood pressure regulates platelet-derived growth factor A-chain gene expression in vascular smooth muscle cells in vivo. An autocrine mechanism promoting hypertensive vascular hypertrophy.
J Clin Invest, 95 (1995), pp. 1140-1150
[71.]
L. Nathan, G. Chaudhuri.
Estrogens and atherosclerosis.
Annu Rev Pharmacol Toxicol, 37 (1997), pp. 477-515
[72.]
E. Falk.
Unstable angina with fatal outcome: dynamic coronary thrombosis leading to infarction and/or sudden death: autopsy evidence of recurrent mural thrombosis with peripheral embolization culminating in total vascular occlusion.
Circulation, 71 (1985), pp. 699-708
[73.]
W.C. Roberts, L.M. Buja.
The frequency and significance of coronary arterial thrombi and other observations in fatal acute myocardial infarction: a study of 107 necropsy patients.
Am J Med, 52 (1972), pp. 425-443
[74.]
H.M. Loree, R.D. Kamm, R.G. Stringfellow, R.T. Lee.
Effects of fibrous cap thickness on peak circumferential stress in model atherosclerotic vessels.
Circ Res, 71 (1992), pp. 850-858
[75.]
P.D. Richardson, M.J. Davies, G.V.R. Born.
Influence of plaque configuration and stress distribution on fissuring of coronary atherosclerotic plaques.
Lancet, 2 (1989), pp. 941-944
[76.]
G. Helft, S.G. Worthley, V. Fuster, Z.A. Fayad, J.I. Osende, A.G. Zaman, et al.
In vivo quantification of atherosclerotic plaque composition by noninvasive high resolution MRI in rabbits: a histopathological correlation.
Jacc, 35 (2000), pp. 478
[77.]
G. Helft, S.G. Worthley, V. Fuster, A.G. Zaman, C. Schechter, J. Osende, et al.
Atherosclerotic aortic component quantification by noninvasive magnetic resonance: an in vivo study in rabbits.
J Am Coll Cardiol, 37 (2001), pp. 1149-1154
[78.]
S.G. Worthley, G. Helft, V. Fuster, Z.A. Fayad, A.G. Zaman, J.T. Fallon, et al.
Serial noninvasive in vivo MRI monitors progression and regression of individual atherosclerotic lesions in a rabbit model.
J Am Coll Cardiol, 35 (2000), pp. 432
[79.]
S.G. Worthley, G. Helft, V. Fuster, A.G. Zaman, Z.A. Fayad, J.T. Fallon, et al.
Serial in vivo MRI documents arterial remodeling in experimental atherosclerosis.
Circulation, 101 (2000), pp. 586-589
[80.]
X.Q. Zhao, C. Yuan, T.S. Hatsukami, E.H. Frechette, X.J. Kang, K.R. Maravilla, et al.
Effects of prolonged intensive lipid-lowering therapy on the characteristics of carotid atherosclerotic plaques in vivo by MRI: a case-control study.
Arterioscler Thromb Vasc Biol, 21 (2001), pp. 1623-1629
[81.]
C.R. Weiss, A.E. Arai, M.H. Bui, K.O. Agyeman, M.A. Waclawiw, R.S. Balaban, et al.
Arterial wall MRi characteristics are associated with elevated serum markers of inflammation in humans.
J Magnetic Res Imaging, 14 (2001), pp. 698-704
[82.]
R.T. Lee, A.J. Grodzinsky, E.H. Frank, R.D. Kamm, F.J. Schoen.
Structure-dependent dynamic mechanical behavior of fibrous caps from human atherosclero-tic plaques.
Circulation, 83 (1991), pp. 1764-1770
[83.]
Y.J. Geng.
Biologic effect and molecular regulation of vascular apoptosis in atherosclerosis.
Curr Atheroscler Rep, 3 (2001), pp. 234-242
[84.]
A. Van der Waal, A. Becker, C. Van der, P. Das Loos.
Site of intimal rupture or erosión of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology.
Circulation, 89 (1994), pp. 36-44
[85.]
A. Fernández-Ortiz, J.J. Badimon, E. Falk, V. Fuster, B.J. Meyer, A. Mailhac, et al.
Characterization of the relative thrombogenicity of atherosclerotic plaque components: Implications for consequences of plaque rupture.
J Am Coll Cardiol, 23 (1994), pp. 1562-1569
[86.]
V. Toschi, R. Gallo, M. Lettino, J.T. Fallon, S. Gertz, A. Fernández-Ortiz, et al.
Tissue factor activity modulates the thrombogenicity of human atherosclerotic plaques.
Circulation, 95 (1997), pp. 594-599
[87.]
J.J. Badimon, M. Lettino, V. Toschi, V. Fuster, M. Berrozpe, J.H. Chesebro, et al.
Local Inhibition of tissue factor reduces the thrombogenicity of disrupted human atherosclerotic plaques.
Circulation, 99 (1999), pp. 1780-1788
[88.]
U. Rauch, J. Osende, J.H. Chesebro, V. Fuster, D.A. Vorchheimer, K. Harris, et al.
Statins and Cardiovascular diseases: multiple effects of lipid-lowering therapy by statins.
Atherosclerosis, 153 (2000), pp. 181-189
[89.]
U. Rauch, J. Crandall, J. Osende, J.T. Fallon, J.H. Chesebro, V. Fuster, et al.
Increased thrombus formation relates to ambient blood glucose and leukocyte count in diabetes mellitus type 2.
Am J Cardiol, 86 (2000), pp. 246-249
[90.]
J. Osende, J.J. Badimon, V. Fuster, P. Herson, P. Rabito, R. Vidhun, et al.
Blood thrombogenicity in type 2 diabetes mellitus patients is associated with glycemic control.
J Am Coll Cardiol, 38 (2001), pp. 1307-1312
[91.]
L. Badimon, P. Martínez-González, T. Royo, R. Lassila, J.J. Badimon.
A sudden increase in plasma epinephrine levels transiently enhances platelet deposition on severely damaged arterial wall. Studies in a porcine model.
Thromb Haemost, 82 (1999), pp. 1736-1742
[92.]
D. Shimbo, J. Child, K. Davidson, E. Geer, J.I. Osende, R. Reddy, et al.
Exaggerated serotonin-mediated platelet reactivity as a possible link in depressión and acute coronary syndromes.
Am J Cardiol, 89 (2002), pp. 331-333
[93.]
A.C. Villablanca, J.M. McDonald, J.C. Rutledge.
Smoking and cardiovascular disease.
Clin Chest Med, 21 (2000), pp. 159-172
[94.]
J.J. Badimon, L. Badimon, V.T. Turitto.
Platelet deposition at high shear rates is enhanced by high plasma cholesterol levels in vivo study in the rabbit model.
Arterioscler Thromb, 11 (1991), pp. 395-402
[95.]
H.N. Ginsberg, L.S. Huang.
The insulin resistance syndrome: impact on lipoprotein metabolism and atherothrombosis.
J Cardiovasc Risk, 7 (2000), pp. 325-331
[96.]
P. Uusimaa, K. Kervinen, A. Kesaniemi, K. Peukurinen.
Serum lipoprotein (a) level in relation to severity of coronary artery disease and coronary artery patency in acute myocardial infarction.
Heart Vessels, 16 (2002), pp. 37-41
Copyright © 2002. Sociedad Española de Arteriosclerosis y Elsevier España, S.L.